The burden of disease in Spain: results from the Global Burden of Disease study 2010

Published December 5, 2014, in BioMed Central (opens in a new window)


We herein evaluate the Spanish population's trends in health burden by comparing results of two Global Burden of Diseases, Injuries, and Risk Factors Studies (the GBD studies) performed 20 years apart.


Data are part of the GBD study for 1990 and 2010. We present results for mortality, years of life lost (YLLs), years lived with disability, and disability-adjusted life years (DALYs) for the Spanish population. Uncertainty intervals for all measures have been estimated.


Non-communicable diseases accounted for 3,703,400 (95% CI 3,648,270–3,766,720) (91.3%) of 4,057,400 total deaths in the Spanish population. Cardiovascular and circulatory diseases were the main cause of mortality among non-communicable diseases (34.7% of total deaths), followed by neoplasms (27.1% of total deaths). Neoplasms, cardiovascular and circulatory diseases, and chronic respiratory diseases were the top three leading causes for YLLs. The most important causes of DALYs in 2010 were neoplasms, cardiovascular and circulatory diseases, musculoskeletal disorders, and mental and behavioral disorders.


Mortality and disability in Spain have become even more linked to non-communicable diseases over the last years, following the worldwide trends. Cardiovascular and circulatory diseases, neoplasms, mental and behavioral disorders, and neurological disorders are the leading causes of mortality and disability. Specific focus is needed from health care providers and policymakers to develop health promotion and health education programs directed toward non-communicable disorders.

Read full article (opens in a new window)


Abad H, Maria J, Tyrovolas S, Garin N, Diaz-Torne C, Carmona L, Riera L, Perez-Ruiz F, Murray C. The burden of disease in Spain: results from the Global Burden of Disease study 2010. BioMed Central. 2014 Dec 5. doi: 10.1186/s12916-014-0236-9. 


Scientific Publication

Global, regional, and national burden of gout, 1990–2020, and projections to 2050